secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2026-08-21T20:05:36+00:00
Accession:  0001104659-26-099678
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth President & CCO Steven Nelson departs Sept 1, 2026; consulting to 2027
--------------------------------------------------------------------------------

- Ceases as President & Chief Commercial Officer effective Sept 1, 2026; employment terminates Sept 30, 2026.
- Separation agreement: earned wages and health coverage through Sept 30; COBRA reimbursement of $2,600/month up to 3 months.
- Consulting agreement Oct 1, 2026–Dec 31, 2027 grants 30,000 restricted shares (vest at 1-yr anniversary or change in control); 15,000 vest immediately if terminated early.
- Outstanding unvested equity awards expire on termination; 6-month non-compete and 12-month non-solicitation apply.
- He will cooperate with transition through Dec 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926099678/0001104659-26-099678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926099678/tm2623745d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-099678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer